Akso Health Group
AHG
$1.71
-$0.03-1.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 512.07% | 401.53% | 281.20% | -29.42% | -81.68% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 512.07% | 401.53% | 281.20% | -29.42% | -81.68% |
| Cost of Revenue | 556.98% | 436.87% | 301.67% | -24.93% | -80.76% |
| Gross Profit | -330.28% | -101.71% | 51.76% | -72.54% | -90.37% |
| SG&A Expenses | -58.43% | -57.40% | -56.85% | -50.44% | -43.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 69.20% | 14.80% | -17.56% | -42.71% | -59.73% |
| Operating Income | 54.58% | 56.86% | 58.06% | 49.39% | 39.45% |
| Income Before Tax | -1,728.80% | -543.58% | 63.03% | 49.21% | 30.42% |
| Income Tax Expenses | -123,304.00% | -55,426.98% | 28.10% | 33.20% | 42.05% |
| Earnings from Continuing Operations | -1,385.93% | -427.94% | 62.88% | 49.08% | 30.32% |
| Earnings from Discontinued Operations | -- | -100.05% | -100.05% | -101.69% | -103.38% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 750.87% | 1,417.35% | 125.36% | 139.35% | 151.42% |
| Net Income | -1,327.00% | -838.35% | -17.06% | -129.64% | -595.60% |
| EBIT | 54.58% | 56.86% | 58.06% | 49.39% | 39.45% |
| EBITDA | -- | 83.64% | 96.27% | 98.15% | -- |
| EPS Basic | -70.58% | -1.33% | 64.83% | -5.23% | -294.63% |
| Normalized Basic EPS | 95.41% | 90.40% | 89.01% | 77.81% | 62.65% |
| EPS Diluted | -64.43% | 1.06% | 62.52% | -0.06% | -200.24% |
| Normalized Diluted EPS | 95.41% | 90.40% | 89.01% | 77.81% | 62.65% |
| Average Basic Shares Outstanding | 504.37% | 524.44% | 565.83% | 336.06% | 106.30% |
| Average Diluted Shares Outstanding | 504.37% | 524.44% | 565.83% | 336.06% | 106.30% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |